Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.
about
Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP PathwayMetabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.Dysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury.Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN)Update on Mechanisms of Renal Tubule Injury Caused by Advanced Glycation End Products.Antilipidemic effects and gene expression profiling of the glycosaminoglycans from cricket in rats on a high fat diet.
P2860
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.
@en
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.
@nl
type
label
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.
@en
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.
@nl
prefLabel
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.
@en
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.
@nl
P2093
P2860
P356
P1476
Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.
@en
P2093
P2860
P304
P356
10.1155/2013/592576
P577
2013-11-27T00:00:00Z